{"name": "Calando Pharmaceuticals",
 "permalink": "calando-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/calando-pharmaceuticals",
 "homepage_url": "http://www.insertt.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "626-683-7200",
 "description": "Nanoparticle BioTech Research",
 "created_at": "Mon Sep 07 09:06:46 UTC 2009",
 "updated_at": "Thu Jan 20 09:21:43 UTC 2011",
 "overview": "\u003Cp\u003ECalando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations. \u003C/p\u003E\n\n\u003Cp\u003ECalando\u00e2\u20ac\u2122s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       63],
      "assets/images/resized/0005/8958/58958v1-max-150x150.jpg"],
     [[250,
       105],
      "assets/images/resized/0005/8958/58958v1-max-250x250.jpg"],
     [[281,
       119],
      "assets/images/resized/0005/8958/58958v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Edward",
      "last_name": "L. Jacobs",
      "permalink": "edward-l-jacobs",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "John",
      "last_name": "Petrovich",
      "permalink": "john-petrovich",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.freshnews.com/news/438489/arrowhead-increases-investment-rnai-subsidiary-calando-pharmaceuticals",
    "source_description": "ARROWHEAD INCREASES INVESTMENT IN RNAI SUBSIDIARY CALANDO PHARMACEUTICALS",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 18,
    "investments":
     [{"company":
        {"name": "Arrowhead Research",
         "permalink": "arrowhead-research",
         "image":
          {"available_sizes":
            [[[150,
               64],
              "assets/images/resized/0009/1004/91004v1-max-150x150.jpg"],
             [[192,
               83],
              "assets/images/resized/0009/1004/91004v1-max-250x250.jpg"],
             [[192,
               83],
              "assets/images/resized/0009/1004/91004v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "129 North Hill Avenue",
    "address2": "Suite 104",
    "zip_code": "91106",
    "city": "Pasadena",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}